Copyright
©The Author(s) 2005.
World J Gastroenterol. Sep 7, 2005; 11(33): 5199-5202
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199
Published online Sep 7, 2005. doi: 10.3748/wjg.v11.i33.5199
Table 4 Recurrence and serum RCAS1, CEA and CA19-9
| Recurrence | RCAS1 (%) | CEA (%) | CA19-9 (%) | RCAS1+CEA (%) | RCAS1+CA19-9 (%) | CA19-9+CEA (%) | ||||||
| Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | Pos | Neg | |
| Yes | 2 | 0 | 1 | 1 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 |
| No | 1 | 12 | 2 | 11 | 1 | 12 | 3 | 10 | 1 | 12 | 3 | 10 |
| Sensitivity | 100 | 50 | 100 | 100 | 100 | 100 | ||||||
| Specificity | 92 | 85 | 92 | 77 | 92 | 77 | ||||||
| Positive predictive value | 67 | 33 | 67 | 40 | 67 | 40 | ||||||
| Negative predictive value | 100 | 92 | 100 | 100 | 100 | 100 | ||||||
| Efficiency | 93 | 80 | 93 | 80 | 93 | 80 | ||||||
- Citation: Yamaguchi K, Enjoji M, Nakashima M, Nakamuta M, Watanabe T, Tanaka M. Novel serum tumor marker, RCAS1, in pancreatic diseases. World J Gastroenterol 2005; 11(33): 5199-5202
- URL: https://www.wjgnet.com/1007-9327/full/v11/i33/5199.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i33.5199